Sarcoma  >>  Viracept (nelfinavir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Viracept (nelfinavir) / ViiV Healthcare, Roche
NCT00002185: A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

Completed
2
20
US
Nelfinavir mesylate
Agouron Pharmaceuticals
Sarcoma, Kaposi, HIV Infections
 
 
NCT00003008: Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Completed
2
33
US
indinavir sulfate, nelfinavir mesylate, paclitaxel, ritonavir, saquinavir mesylate
Eastern Cooperative Oncology Group, National Cancer Institute (NCI), AIDS Associated Malignancies Clinical Trials Consortium
Sarcoma
06/06
 
NCT03077451: Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

Completed
2
36
US, RoW
Laboratory Biomarker Analysis, Nelfinavir Mesylate, AG1343, Viracept
AIDS Malignancy Consortium, National Cancer Institute (NCI), The Emmes Company, LLC, University of Arkansas, University of California, Los Angeles, AIDS and Cancer Specimen Resource, Montefiore Medical Center
Recurrent Kaposi Sarcoma, Skin Kaposi Sarcoma
05/22
04/23
NCT00233948: Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma

Checkmark P1 data- ESMO 2012
Sep 2012 - Sep 2012: P1 data- ESMO 2012
Terminated
1/2
29
US
nelfinavir mesylate, Viracept, biopsy, biopsies, laboratory biomarker analysis, pharmacological study, pharmacological studies, gene expression analysis, western blotting, Blotting, Western, Western Blot, reverse transcriptase-polymerase chain reaction, RT-PCR, immunoenzyme technique, immunoenzyme techniques
City of Hope Medical Center
Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
07/13
 

Download Options